 | • レポートコード：QYR9ST03052 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の破傷風ワクチン市場について調査・分析し、以下の構成でお届け致します。破傷風ワクチンの種類別には、ジフテリア及び破傷風（DT）ワクチン、ジフテリア、破傷風、及び百日咳（百日咳）（DTaP）ワクチン、破傷風及びジフテリア（Td）ワクチン、破傷風、ジフテリア、及び百日咳（Tdap）ワクチンに、用途別には、大人、小児に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別破傷風ワクチン売上データ ・地域別破傷風ワクチン市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別破傷風ワクチン市場規模：ジフテリア及び破傷風（DT）ワクチン、ジフテリア、破傷風、及び百日咳（百日咳）（DTaP）ワクチン、破傷風及びジフテリア（Td）ワクチン、破傷風、ジフテリア、及び百日咳（Tdap）ワクチン ・用途別破傷風ワクチン市場規模：大人、小児 ・主要メーカーの企業情報：GlaxoSmithKline plc、Pfizer,Inc、Merck & Co.,Inc、Sanofi Pasteur SA、Biological E、Dano Vaccine &Biological Pvt.Ltd.,、Panera、Shantha Biotechnics Ltd ・破傷風ワクチンの市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date on their tetanus immunization a booster should be given within 48 hours of an injury. In those with high risk injuries who are not fully immunized tetanus antitoxin may also be recommended. Making sure women who are pregnant are up to date on their tetanus immunization and, if not, immunizing them can prevent neonatal tetanus.
The vaccine is very safe including during pregnancy and in those with HIV/AIDS. Redness and pain at the site of injection occur in between 25% and 85% of people. Fever, feeling tired, and minor muscles pains occur in less than 10% of people. Severe allergic reactions occur in less than one in 100,000 people.
A number of vaccine combinations include the tetanus vaccine such as DTaP and Tdap which contain diphtheria, tetanus, and pertussis vaccine, and DT and Td which contain diphtheria and tetanus vaccine. DTaP and DT are given to children less than seven years old while Tdap and Td are given to those seven years old and older. The lowercase d and p denote lower strengths of diphtheria and pertussis vaccines.
The tetanus vaccine was developed in 1924 and became available in the United States in the 1940s. Its use resulted in a 95% decrease in the rate of tetanus. It is on the World Health Organization’s List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.In the United States a course of tetanus vaccine is between 25 and 50 USD.
The global Tetanus Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Tetanus Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Tetanus Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tetanus Vaccine in these regions.
This research report categorizes the global Tetanus Vaccine market by top players/brands, region, type and end user. This report also studies the global Tetanus Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline plc
Pfizer,Inc
Merck & Co.,Inc
Sanofi Pasteur SA
Biological E
Dano Vaccine &Biological Pvt.Ltd.,
Panera
Shantha Biotechnics Ltd
Market size by Product
Diphtheria and tetanus (DT) vaccines
Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
Tetanus and diphtheria (Td) vaccines
Tetanus, diphtheria, and pertussis (Tdap) vaccines
Market size by End User
Adult
Pediatric
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Tetanus Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Tetanus Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Tetanus Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Tetanus Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Tetanus Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tetanus Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Tetanus Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Tetanus Vaccine Market Size Growth Rate by Product
1.4.2 Diphtheria and tetanus (DT) vaccines
1.4.3 Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
1.4.4 Tetanus and diphtheria (Td) vaccines
1.4.5 Tetanus, diphtheria, and pertussis (Tdap) vaccines
1.5 Market by End User
1.5.1 Global Tetanus Vaccine Market Size Growth Rate by End User
1.5.2 Adult
1.5.3 Pediatric
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tetanus Vaccine Market Size
2.1.1 Global Tetanus Vaccine Revenue 2014-2025
2.1.2 Global Tetanus Vaccine Sales 2014-2025
2.2 Tetanus Vaccine Growth Rate by Regions
2.2.1 Global Tetanus Vaccine Sales by Regions
2.2.2 Global Tetanus Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Tetanus Vaccine Sales by Manufacturers
3.1.1 Tetanus Vaccine Sales by Manufacturers
3.1.2 Tetanus Vaccine Sales Market Share by Manufacturers
3.1.3 Global Tetanus Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Tetanus Vaccine Revenue by Manufacturers
3.2.1 Tetanus Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Tetanus Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Tetanus Vaccine Price by Manufacturers
3.4 Tetanus Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Tetanus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tetanus Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Tetanus Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Tetanus Vaccine Sales by Product
4.2 Global Tetanus Vaccine Revenue by Product
4.3 Tetanus Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Tetanus Vaccine Breakdown Data by End User
6 North America
6.1 North America Tetanus Vaccine by Countries
6.1.1 North America Tetanus Vaccine Sales by Countries
6.1.2 North America Tetanus Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Tetanus Vaccine by Product
6.3 North America Tetanus Vaccine by End User
7 Europe
7.1 Europe Tetanus Vaccine by Countries
7.1.1 Europe Tetanus Vaccine Sales by Countries
7.1.2 Europe Tetanus Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tetanus Vaccine by Product
7.3 Europe Tetanus Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Tetanus Vaccine by Countries
8.1.1 Asia Pacific Tetanus Vaccine Sales by Countries
8.1.2 Asia Pacific Tetanus Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Tetanus Vaccine by Product
8.3 Asia Pacific Tetanus Vaccine by End User
9 Central & South America
9.1 Central & South America Tetanus Vaccine by Countries
9.1.1 Central & South America Tetanus Vaccine Sales by Countries
9.1.2 Central & South America Tetanus Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Tetanus Vaccine by Product
9.3 Central & South America Tetanus Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Tetanus Vaccine by Countries
10.1.1 Middle East and Africa Tetanus Vaccine Sales by Countries
10.1.2 Middle East and Africa Tetanus Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Tetanus Vaccine by Product
10.3 Middle East and Africa Tetanus Vaccine by End User
11 Company Profiles
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Company Details
11.1.2 Company Business Overview
11.1.3 GlaxoSmithKline plc Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 GlaxoSmithKline plc Tetanus Vaccine Products Offered
11.1.5 GlaxoSmithKline plc Recent Development
11.2 Pfizer,Inc
11.2.1 Pfizer,Inc Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer,Inc Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer,Inc Tetanus Vaccine Products Offered
11.2.5 Pfizer,Inc Recent Development
11.3 Merck & Co.,Inc
11.3.1 Merck & Co.,Inc Company Details
11.3.2 Company Business Overview
11.3.3 Merck & Co.,Inc Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck & Co.,Inc Tetanus Vaccine Products Offered
11.3.5 Merck & Co.,Inc Recent Development
11.4 Sanofi Pasteur SA
11.4.1 Sanofi Pasteur SA Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi Pasteur SA Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi Pasteur SA Tetanus Vaccine Products Offered
11.4.5 Sanofi Pasteur SA Recent Development
11.5 Biological E
11.5.1 Biological E Company Details
11.5.2 Company Business Overview
11.5.3 Biological E Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Biological E Tetanus Vaccine Products Offered
11.5.5 Biological E Recent Development
11.6 Dano Vaccine &Biological Pvt.Ltd.,
11.6.1 Dano Vaccine &Biological Pvt.Ltd., Company Details
11.6.2 Company Business Overview
11.6.3 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Products Offered
11.6.5 Dano Vaccine &Biological Pvt.Ltd., Recent Development
11.7 Panera
11.7.1 Panera Company Details
11.7.2 Company Business Overview
11.7.3 Panera Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Panera Tetanus Vaccine Products Offered
11.7.5 Panera Recent Development
11.8 Shantha Biotechnics Ltd
11.8.1 Shantha Biotechnics Ltd Company Details
11.8.2 Company Business Overview
11.8.3 Shantha Biotechnics Ltd Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Shantha Biotechnics Ltd Tetanus Vaccine Products Offered
11.8.5 Shantha Biotechnics Ltd Recent Development
12 Future Forecast
12.1 Tetanus Vaccine Market Forecast by Regions
12.1.1 Global Tetanus Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Tetanus Vaccine Revenue Forecast by Regions 2019-2025
12.2 Tetanus Vaccine Market Forecast by Product
12.2.1 Global Tetanus Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Tetanus Vaccine Revenue Forecast by Product 2019-2025
12.3 Tetanus Vaccine Market Forecast by End User
12.4 North America Tetanus Vaccine Forecast
12.5 Europe Tetanus Vaccine Forecast
12.6 Asia Pacific Tetanus Vaccine Forecast
12.7 Central & South America Tetanus Vaccine Forecast
12.8 Middle East and Africa Tetanus Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tetanus Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Tetanus Vaccine Product Picture
Table Tetanus Vaccine Market Segments
Table Key Manufacturers Tetanus Vaccine Covered
Table Global Tetanus Vaccine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Tetanus Vaccine Sales Market Share by Product 2014-2025
Figure Diphtheria and tetanus (DT) vaccines Product Picture
Table Major Manufacturers of Diphtheria and tetanus (DT) vaccines
Figure Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines Product Picture
Table Major Manufacturers of Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
Figure Tetanus and diphtheria (Td) vaccines Product Picture
Table Major Manufacturers of Tetanus and diphtheria (Td) vaccines
Figure Tetanus, diphtheria, and pertussis (Tdap) vaccines Product Picture
Table Major Manufacturers of Tetanus, diphtheria, and pertussis (Tdap) vaccines
Table Global Tetanus Vaccine Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Adult
Figure Pediatric
Figure Tetanus Vaccine Report Years Considered
Figure Global Tetanus Vaccine Market Size 2014-2025 (Million US$)
Figure Global Tetanus Vaccine Sales 2014-2025 (K Units)
Table Global Tetanus Vaccine Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Tetanus Vaccine Sales by Regions 2014-2019 (K Units)
Table Global Tetanus Vaccine Sales Market Share by Regions 2014-2019
Figure Global Tetanus Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global Tetanus Vaccine Sales Market Share by Regions
Table Global Tetanus Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Tetanus Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Tetanus Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Tetanus Vaccine Revenue Market Share by Regions
Table Global Tetanus Vaccine Sales by Manufacturers (2014-2019) (K Units)
Table Global Tetanus Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Tetanus Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Tetanus Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Tetanus Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Tetanus Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers Tetanus Vaccine Price (2014-2019) (USD/Unit)
Table Tetanus Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Tetanus Vaccine Product Type
Table Date of International Manufacturers Enter into Tetanus Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Tetanus Vaccine Sales by Product (2014-2019) (K Units)
Table Global Tetanus Vaccine Sales Share by Product (2014-2019)
Figure Global Tetanus Vaccine Sales Market Share by Product (2014-2019)
Figure Global Tetanus Vaccine Sales Market Share by Product in 2018
Table Global Tetanus Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global Tetanus Vaccine Revenue Share by Product (2014-2019)
Figure Global Tetanus Vaccine Revenue Market Share by Product (2014-2019)
Figure Global Tetanus Vaccine Revenue Market Share by Product in 2018
Table Tetanus Vaccine Price by Product 2014-2019 (USD/Unit)
Table Global Tetanus Vaccine Sales by End User (2014-2019) (K Units)
Table Global Tetanus Vaccine Sales Share by End User (2014-2019)
Figure Global Sales Tetanus Vaccine Market Share by End User (2014-2019)
Figure Global Sales Tetanus Vaccine Market Share by End User in 2018
Figure North America Tetanus Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure North America Tetanus Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Tetanus Vaccine Sales by Countries (2014-2019) (K Units)
Table North America Tetanus Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Tetanus Vaccine Sales Market Share by Countries
Table North America Tetanus Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Tetanus Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Tetanus Vaccine Revenue Market Share by Countries
Figure United States Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure United States Tetanus Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Canada Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Tetanus Vaccine Sales by Product (2014-2019) (K Units)
Table North America Tetanus Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America Tetanus Vaccine Market Share by Product
Table North America Tetanus Vaccine Sales by End User (2014-2019) (K Units)
Table North America Tetanus Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America Tetanus Vaccine Market Share by End User
Figure Europe Tetanus Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Europe Tetanus Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Tetanus Vaccine Sales by Countries (2014-2019) (K Units)
Table Europe Tetanus Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Tetanus Vaccine Sales Market Share by Countries
Table Europe Tetanus Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Tetanus Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Tetanus Vaccine Revenue Market Share by Countries
Figure Germany Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Germany Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure France Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure UK Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Italy Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Russia Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Tetanus Vaccine Sales by Product (2014-2019) (K Units)
Table Europe Tetanus Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Tetanus Vaccine Market Share by Product
Table Europe Tetanus Vaccine Sales by End User (2014-2019) (K Units)
Table Europe Tetanus Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Tetanus Vaccine Market Share by End User
Figure Asia Pacific Tetanus Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Tetanus Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Tetanus Vaccine Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Tetanus Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Tetanus Vaccine Sales Market Share by Countries
Table Asia Pacific Tetanus Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Tetanus Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Tetanus Vaccine Revenue Market Share by Countries
Figure China Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure China Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Japan Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Korea Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure India Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Australia Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Tetanus Vaccine Sales by Product (2014-2019) (K Units)
Table Asia Pacific Tetanus Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Tetanus Vaccine Market Share by Product
Table Asia Pacific Tetanus Vaccine Sales by End User (2014-2019) (K Units)
Table Asia Pacific Tetanus Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Tetanus Vaccine Market Share by End User
Figure Central & South America Tetanus Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Tetanus Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Tetanus Vaccine Sales by Countries (2014-2019) (K Units)
Table Central & South America Tetanus Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Tetanus Vaccine Sales Market Share by Countries
Table Central & South America Tetanus Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Tetanus Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Tetanus Vaccine Revenue Market Share by Countries
Figure Brazil Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Tetanus Vaccine Sales by Product (2014-2019) (K Units)
Table Central & South America Tetanus Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Tetanus Vaccine Market Share by Product
Table Central & South America Tetanus Vaccine Sales by End User (2014-2019) (K Units)
Table Central & South America Tetanus Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Tetanus Vaccine Market Share by End User
Figure Middle East and Africa Tetanus Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Tetanus Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Tetanus Vaccine Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Tetanus Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Tetanus Vaccine Sales Market Share by Countries
Table Middle East and Africa Tetanus Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Tetanus Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Tetanus Vaccine Revenue Market Share by Countries
Figure GCC Countries Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Tetanus Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Tetanus Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Tetanus Vaccine Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Tetanus Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Tetanus Vaccine Market Share by Product
Table Middle East and Africa Tetanus Vaccine Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Tetanus Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Tetanus Vaccine Market Share by End User
Table GlaxoSmithKline plc Company Details
Table GlaxoSmithKline plc Tetanus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline plc Recent Development
Table Pfizer,Inc Company Details
Table Pfizer,Inc Tetanus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer,Inc Recent Development
Table Merck & Co.,Inc Company Details
Table Merck & Co.,Inc Tetanus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co.,Inc Recent Development
Table Sanofi Pasteur SA Company Details
Table Sanofi Pasteur SA Tetanus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Pasteur SA Recent Development
Table Biological E Company Details
Table Biological E Tetanus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biological E Recent Development
Table Dano Vaccine &Biological Pvt.Ltd., Company Details
Table Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Dano Vaccine &Biological Pvt.Ltd., Recent Development
Table Panera Company Details
Table Panera Tetanus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Panera Recent Development
Table Shantha Biotechnics Ltd Company Details
Table Shantha Biotechnics Ltd Tetanus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Shantha Biotechnics Ltd Recent Development
Table Global Tetanus Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Table Global Tetanus Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Tetanus Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Tetanus Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global Tetanus Vaccine Sales Forecast by Product 2019-2025 (K Units)
Table Global Tetanus Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global Tetanus Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Tetanus Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global Tetanus Vaccine Sales Forecast by End User 2019-2025 (K Units)
Table Global Tetanus Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America Tetanus Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Tetanus Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Tetanus Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Tetanus Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Tetanus Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Tetanus Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Tetanus Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Tetanus Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Tetanus Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Tetanus Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Tetanus Vaccine Value Chain
Table Tetanus Vaccine Customers List
Table Tetanus Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
ジフテリア・百日咳・破傷風ワクチンの世界市場：インサイト・予測 Diphtheria, pertussis, and tetanus (DPT) vaccine is administered for three infectious diseases in humans-diphtheria, tetanus, and pertussis. They are administered either in childhood or middle age to produce the acquired immunity against diphtheria, pertussis, and tetanus.Global Diphtheria, Pertussi…- 世界のジフテリアワクチン市場：専門的調査 Diphtheria is a bacterial infection caused by Corynebacterium diphtheriae, and it spreads through respiratory droplets and close physical contact. Diphtheria Vaccine is a vaccine produced from diphtheria toxoid (a non-toxic form of the toxin) that against Corynebacterium diphtheriae. The global Diph…
- 世界のトキソイドワクチン市場：専門的調査 For bacteria that secrete toxins, or harmful chemicals, a toxoid vaccine might be the answer. These vaccines are used when a bacterial toxin is the main cause of illness. Scientists have found that they can inactivate toxins by treating them with formalin, a solution of formaldehyde and sterilized w…
- 世界の組換えベクターワクチン市場：専門的調査 Recombinant vector vaccines are experimental vaccines similar to DNA vaccines, but they use an attenuated virus or bacterium to introduce microbial DNA to cells of the body. “Vector” refers to the virus or bacterium used as the carrier.In nature, viruses latch on to cells and inject their genetic ma…
- 世界のヒトワクチン市場：専門的調査 A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. China …